A20 haploinsufficiency disturbs immune homeostasis and drives the transformation of lymphocytes with permissive antigen receptors

A20单倍体不足会扰乱免疫稳态,并驱动具有容许性抗原受体的淋巴细胞发生转化。

阅读:11
作者:Christoph Schultheiß,Lisa Paschold,Alma Nazlie Mohebiany,Moritz Escher,Yogita Mallu Kattimani,Melanie Müller,Paul Schmidt-Barbo,Anna Mensa-Vilaró,Juan Ignacio Aróstegui,Guilaine Boursier,Claire de Moreuil,Timo Hautala,Edith Willscher,Hanna Jonas,Namuun Chinchuluun,Bianca Grosser,Bruno Märkl,Wolfram Klapper,Prasad Thomas Oommen,Katharina Gössling,Katrin Hoffmann,Gisa Tiegs,Felix Czernilofsky,Sascha Dietrich,Alexandra Freeman,Daniella M Schwartz,Ari Waisman,Ivona Aksentijevich,Mascha Binder

Abstract

Genetic TNFAIP3 (A20) inactivation is a classical somatic lymphoma lesion and the genomic trait in haploinsufficiency of A20 (HA20). In a cohort of 34 patients with HA20, we show that heterozygous TNFAIP3 loss skews immune repertoires toward lymphocytes with classical self-reactive antigen receptors typically found in B and T cell lymphomas. This skewing was mediated by a feed-forward tumor necrosis factor (TNF)/A20/nuclear factor κB (NF-κB) loop that shaped pre-lymphoma transcriptome signatures in clonally expanded B (CD81, BACH2, and NEAT1) or T (GATA3, TOX, and PDCD1) cells. The skewing was reversed by anti-TNF treatment but could also progress to overt lymphoma. Analysis of conditional TNFAIP3 knock-out mice reproduced the wiring of the TNF/A20/NF-κB signaling axis with permissive antigen receptors and suggested a distinct regulation in B and T cells. Together, patients with the genetic disorder HA20 provide an exceptional window into A20/TNF/NF-κB-mediated control of immune homeostasis and early steps of lymphomagenesis that remain clinically unrecognized.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。